Diatide Research Laboratories
http://www.diatide.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Diatide Research Laboratories
Schering: Building Franchises
Germany's Schering AG is betting it can crack the US market using a franchise of smaller products, rather than relying on a single blockbuster. It reckons this strategy--which few have used before--is best suited to its size and strengths.
Good News for a Small-Cap Imaging Company
Schering AG's purchase of Diatide Inc. appears to be an exception to the general rule that, while small-cap acquisitions are at an all-time high, the shareholders of acquired companies don't fare particularly well. Schering areed to pay a significant premium over the the Diatide stock price just prior to the deal, despite the fact that Nycomed Amersham PLC owns partial rights to Diatides two late-stage products. Schering was willing to pay the price because of its commitment to developing a franchise in nuclear imaging.
Angstrom Pharmaceuticals Inc.
Structure-based design of small-molecule, non-toxic, angiogenesis inhibitor drugs for treating cancer
Company Information
- Industry
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
- Other Names / Subsidiaries
-
- Diatech Diagnostics, Diatide Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice